Pharmacology Imatinib used in CML acts by – A Inhibiting BCR/ABL translocation tyrosine kinase B Blocking the action of P glycoprotein C Competitive inhibition ofATP binding site ofABL kinase D C-Kit kinase inhibition π‘ Explanation Imatinib used in CML acts by - β Correct Answer: C. Competitive inhibition ofATP binding site ofABL kinase